Literature DB >> 18791834

Benzodiazepine-mediated structural changes in the multidrug transporter P-glycoprotein: an intrinsic fluorescence quenching analysis.

Sofia A C Lima1, Anabela Cordeiro-da-Silva, Baltazar de Castro, Paula Gameiro.   

Abstract

P-glycoprotein expressed in Pichia pastoris was used to study the drug binding sites of different benzodiazepines. The effect of bromazepam, chlordiazepoxide, diazepam and flurazepam on P-glycoprotein structure was investigated by measuring the intrinsic fluorescence of the transporter tryptophan residues. Purified mouse mdr1a transporter in mixed micelles of 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonic acid and 1,2-dimiristoyl-sn-glycerol-3-phosphocholine emitted fluorescence at 340 nm indicative of the fluorophores in a relatively apolar environment. Acrylamide and iodide ion were used as collisional quenchers toward distinct regions of the transporter, the protein and the interface protein-surface, respectively. Binding of ATP induced conformational changes at the protein surface level in accordance with the location of the nucleotide binding sites. Bromazepam interaction with the transporter was located at the protein-surface interface, diazepam at the membrane region and chlordiazepoxide at the protein surface. Only the flurazepam interaction site was not detected by the quenchers used. All benzodiazepines were able to elicit reorientation of the protein fluorophores on the P-glycoprotein-ATP complex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791834     DOI: 10.1007/s00232-008-9117-5

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  49 in total

1.  Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil.

Authors:  T W Loo; D M Clarke
Journal:  J Biol Chem       Date:  2001-02-14       Impact factor: 5.157

2.  Domain mapping of the photoaffinity drug-binding sites in P-glycoprotein encoded by mouse mdr1b.

Authors:  L M Greenberger; C J Lisanti; J T Silva; S B Horwitz
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

3.  Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of wild-type, Walker A, and Walker B mutant proteins.

Authors:  N Lerner-Marmarosh; K Gimi; I L Urbatsch; P Gros; A E Senior
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

4.  Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein.

Authors:  I L Urbatsch; M K al-Shawi; A E Senior
Journal:  Biochemistry       Date:  1994-06-14       Impact factor: 3.162

5.  Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.

Authors:  M J Borgnia; G D Eytan; Y G Assaraf
Journal:  J Biol Chem       Date:  1996-02-09       Impact factor: 5.157

6.  MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping.

Authors:  A J Smith; A van Helvoort; G van Meer; K Szabo; E Welker; G Szakacs; A Varadi; B Sarkadi; P Borst
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

7.  Drug binding sites on P-glycoprotein are altered by ATP binding prior to nucleotide hydrolysis.

Authors:  C Martin; G Berridge; P Mistry; C Higgins; P Charlton; R Callaghan
Journal:  Biochemistry       Date:  2000-10-03       Impact factor: 3.162

8.  Vanadate trapping of nucleotide at the ATP-binding sites of human multidrug resistance P-glycoprotein exposes different residues to the drug-binding site.

Authors:  Tip W Loo; David M Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

9.  Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

10.  Both P-glycoprotein nucleotide-binding sites are catalytically active.

Authors:  I L Urbatsch; B Sankaran; S Bhagat; A E Senior
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

View more
  1 in total

1.  Fluorescence quenching as a tool to investigate quinolone antibiotic interactions with bacterial protein OmpF.

Authors:  Patrícia Neves; Isabel Sousa; Mathias Winterhalter; Paula Gameiro
Journal:  J Membr Biol       Date:  2009-01-16       Impact factor: 1.843

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.